↓ Skip to main content

Dove Medical Press

Assessing Palatability of a New Amphetamine Extended-Release Tablet Formulation for the Treatment of ADHD

Overview of attention for article published in Drug Design, Development and Therapy, July 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#12 of 2,276)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
38 news outlets

Readers on

mendeley
32 Mendeley
Title
Assessing Palatability of a New Amphetamine Extended-Release Tablet Formulation for the Treatment of ADHD
Published in
Drug Design, Development and Therapy, July 2021
DOI 10.2147/dddt.s309378
Pubmed ID
Authors

Antonio Pardo, Thomas R King, Eman Rafla, Judith C Kando

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 9%
Researcher 2 6%
Lecturer 2 6%
Unspecified 1 3%
Student > Master 1 3%
Other 1 3%
Unknown 22 69%
Readers by discipline Count As %
Nursing and Health Professions 3 9%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Medicine and Dentistry 2 6%
Psychology 2 6%
Biochemistry, Genetics and Molecular Biology 1 3%
Other 1 3%
Unknown 21 66%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 270. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 July 2022.
All research outputs
#134,862
of 25,655,374 outputs
Outputs from Drug Design, Development and Therapy
#12
of 2,276 outputs
Outputs of similar age
#3,979
of 455,354 outputs
Outputs of similar age from Drug Design, Development and Therapy
#1
of 59 outputs
Altmetric has tracked 25,655,374 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,276 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 455,354 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 59 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.